Play Health

Perimenopause reaches nearly every woman, and the care around it misses often. Around 1.3 million American women reach menopause each year. Nearly four in ten who seek care for perimenopause symptoms report being misdiagnosed, usually treated for anxiety or depression instead. Only 39% of providers treating women’s health feel very confident managing menopause symptoms. The failure happens inside the appointment, which is where Play Health puts its product.

Spending on menopause is already large. Grand View Research values the global menopause market at $17.79 billion in 2024, rising to $24.35 billion by 2030. The digital share is growing three times faster. Menopause care femtech is projected to move from $3.04 billion in 2024 to $7.45 billion by 2030.

Menopause care runs through primary care, OB/GYN practices, menopause specialists and a growing set of virtual clinics. Hims & Hers, the publicly traded consumer health company, launched a menopause and perimenopause specialty in October 2025. Employers and health-benefit programs are buying midlife women's health as a covered service.

The gap sits in training and confidence. Only 39% of surveyed providers treating women’s health feel very confident managing menopause symptoms. Lack of provider education is the barrier they name most often. A peer-reviewed survey of US OB/GYN residency program directors found 31.3% reporting any menopause curriculum. Providers also rarely hold longitudinal symptom data between appointments, so a short visit depends on patient recall.

The buyers are already reaching for a fix. Providers name menopause care as the area they expect to improve most within five years. 72% report growth in cash-pay and direct-to-consumer menopause services. Women meanwhile track sleep, cycles and activity on consumer wearables, so the data already exists outside the clinic.

Play Health places itself inside the existing care relationship rather than beside it. Virtual menopause clinics compete for the patient directly. Play Health instead equips the provider the patient already sees, which keeps the referral pattern intact.

Spending on menopause is established and virtual menopause clinics are funded, yet most appointments still happen without longitudinal patient data. That leaves room for a decision-support layer inside the visit itself.

Play Health builds menopause decision support for the clinicians women already see. It targets primary care providers, OB/GYNs, menopause specialists and concierge practices. The product connects patient-tracked symptom data to evidence-based next steps at the point of care.

Both halves of the product are live. The patient app has shipped four major versions since October 2025 and is available on iOS, Android and web. The clinician dashboard is sold at a published price. Wearable integrations are in production.